A detailed history of Ieq Capital, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 11,424 shares of PACB stock, worth $19,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,424
Previous 11,424 -0.0%
Holding current value
$19,649
Previous $15,000 26.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$1.36 - $3.65 $63 - $171
-47 Reduced 0.41%
11,424 $15,000
Q1 2024

May 08, 2024

BUY
$3.52 - $9.59 $165 - $450
47 Added 0.41%
11,471 $43,000
Q1 2022

Apr 26, 2022

BUY
$8.43 - $20.9 $96,304 - $238,761
11,424 New
11,424 $104,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $387M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.